Evidence map›Paper›PMID 37706005›Full record

ArticleJournal of clinical and translational science2023

Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action.

Dan M Cooper, Mark A Rothstein, Alpesh Amin, Jan D Hirsch, Emma Cooper

Abstract readEditorial
In one paragraph

Article in Journal of clinical and translational science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Comparison of Pediatric and Adult Glucagon-Like Peptide-1 Receptor Agonist Exposures Reported To United States Poison Centers, 2017-2024.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2026
    Article
  5. The ethics of Wegovy: promoting autonomy in pediatric care.Medicine, health care, and philosophy · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dan M CooperDepartment of Pediatrics, School of Medicine, Institute for Clinical and Translational Science, University of California at Irvine, Irvine, CA, USA.ORCID https://orcid.org/0000-0003-4022-0043
Mark A RothsteinUniversity of California at Irvine, Institute for Clinical and Translational Science, Irvine, CA, USA.
Alpesh AminDepartment of Medicine, School of Medicine, University of California at Irvine, Irvine, CA, USA.
Jan D HirschSchool of Pharmacy and Pharmaceutical Sciences, University of California at Irvine, Irvine, CA, USA.
Emma CooperDepartment of Psychiatry, School of Medicine, University of California at Irvine, Irvine, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adolescentappetite suppressantdrug abuseeating disordersenergy expenditurePediatricunexpected effects

Identifiers

PMID37706005
PMCPMC10495825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.